Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001437749-25-028482
Filing Date
2025-09-05
Accepted
2025-09-05 16:15:42
Documents
15
Effectiveness Date
2025-09-05
Reference 429
333-279987

Document Format Files

Seq Description Document Type Size
1 FORM S-8 clnn20250521_s8.htm S-8 42728
2 EXHIBIT 5.1 ex_822012.htm EX-5.1 14122
3 EXHIBIT 23.2 ex_822013.htm EX-23.2 1974
4 FILING FEE TABLE ex_822014.htm   iXBRL EX-FILING FEES 16312
5 hklogo35px.jpg GRAPHIC 8086
  Complete submission text file 0001437749-25-028482.txt   206508

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT ex_822014_htm.xml XML 4910
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

EIN.: 852828339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-290072 | Film No.: 251296942
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)